|
MICAL-L2, as an estrogen-responsive gene, is involved in ER-positive breast cancer cell progression and tamoxifen sensitivity via the AKT/mTOR pathway |
|
|
|
Title: |
MICAL-L2, as an estrogen-responsive gene, is involved in ER-positive breast cancer cell progression and tamoxifen sensitivity via the AKT/mTOR pathway |
Author: |
Wen, Pushuai Li, Jing Wen, Zihao Guo, Xiaoyan Ma, Guoqun Hu, Shuzhen Xu, Jiamei Zhao, Hongli Li, Ruixin Liu, Ying Wang, Yu Gao, Jing |
Appeared in: |
Biochemical pharmacology |
Paging: |
Volume 225 () nr. C pages p. |
Year: |
2024 |
Contents: |
|
Publisher: |
Elsevier Inc. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|